Latest news for Freee (OTC:FREKF) Stock

Freee KK is a developer of cloud-based software. Its software products include Cloud Accounting software, Cloud HR Labor software, Cloud ERP for Midsize companies, among others.

Freee KK

<p><strong>BioNexus Gene Lab Corp.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>, the "Company")))), an emerging biotechnology company focused on innovative healthcare solutions, is pleased to announce that its wholly owned subsidiary, <strong>MRNA Scientific Sdn. Bhd. </strong>("MRNA Scientific"), has entered into a strategic outsourcing agreement with <strong>VITARRAY Global Pte. Ltd. </strong>("Vitarray"), an exempted private company incorporated in Singapore. This agreement focuses on the provision of <strong>mRNA dynamic gene detection services</strong> for the Southeast Asian market.<br /><br />&nbsp;</p>
<p>Under this agreement, <strong>MRNA Scientific </strong>will leverage its advanced medical testing facilities located in <strong>Kuala Lumpur, Malaysia</strong>, to provide <strong>outsourcing services</strong> for Vitarray's mRNA gene detection activities. This collaboration is aimed at enhancing the deployment of <strong>advanced molecular diagnostics</strong> throughout Southeast Asia, facilitating early disease detection and expanding access to innovative healthcare technologies.</p>


Biotech

News

General

BGLC

BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement With VITARRAY Global Pte. Ltd. Focusing On The Provision Of mRNA Dynamic Gene Detection Services For The Southeast Asian Market

<p>When markets are climbing, many traders who sold early often regret their decision. They watch as the stocks they sold continue to rise, missing out <a href="https://www.benzinga.com/topic/bull-market">on further gains.</a></p>
<p>This seller&#8217;s remorse, a common phenomenon in bull markets, is often visible on stock charts, as traders rush to buy back shares they sold too soon. That's why <strong>Wells Fargo &amp; Company </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) is our Stock of the Day. It is an excellent example of this price action</p>
<p>As you can see on the chart, the $46.80 level was resistance in July 2023. After hitting this resistance, the stock reversed and went lower.</p>
<p><figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="636" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/13115916/wfc-chart-1024x636.png" alt="" class="wp-image-547351" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/13115916/wfc-chart-1024x636.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/13115916/wfc-chart-300x186.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/13115916/wfc-chart-768x477.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/13115916/wfc-chart.png 1176w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p>But in December 2023 the resistance was broken and the shares moved higher. When this occurred, some of the traders and investors who sold while the stock was at resistance came to regret their decisions to do so.</p>
<p>Some remorseful sellers decided to buy their shares back at the same price they had sold them, hoping to undo the mistake they felt they made by selling too early.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/personal-finance/24/09/40856618/bill-gates-says-working-less-than-full-time-sounds-awful-and-warren-buffett-still-comes-into-the">Bill Gates Says Working Less Than Full Time &#8216;Sounds Awful&#8217; And &#8216;Warren Buffett Still Comes Into The Office Six Days A Week&#8217;</a></strong></p>
<p>As a result, after Wells Fargo sold off and returned to the $46.80 level, these remorseful sellers placed buy orders. There were so many of them that it created support at the same price level that had previously been resistance.</p>
<p>The next important resistance was the $51.20 level. The shares stalled out here in early February. Then in late February, this resistance was broken and the stock took off.</p>
<p>When this happened a number of those who sold while the shares were at resistance came to think they made a mistake. So, they decide that they will buy their shares back if they can eventually do so at the same price they were sold for.</p>
<p>When the price eventually dropped back to this level in August, they placed buy orders. And there were so many of these orders that it created support at the same price that had been resistance.</p>
<p>Price levels that were resistance can convert into support. This is a common occurrence in the financial markets. It happens because of sellers' remorse, and the chart of Wells <a href="https://www.benzinga.com/quote/WFC">Fargo</a> is a good example of it.</p>
<p><strong>Read Next:</strong> </p>
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40850544/wall-street-eyes-strong-finish-to-the-week-despite-futures-suggesting-moderation-in-tech-buying-str"><strong>Wall Street Eyes Strong Finish To The Week Despite Futures Suggesting Moderation In Tech Buying: Strategist Cautions Against Factoring Rapid, Steep Cuts Ahead Of Next Week&#8217;s Fed Meeting</strong></a></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Technicals

Trading Ideas

Stock Of The Day: Regretful Sellers Rebuy Their Wells Fargo Shares

<p>- Morgan Stanley's 12th Annual Laguna Conference 2024</p>


Boeing CFO Says Long Term Fundamentals Of Business Haven't Changed But It Has Moved To The Right

<p>During the last three months, 4 analysts shared their evaluations of Evolus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOLS#NASDAQ">EOLS</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $22.75, a high estimate of $27.00, and a low estimate of $20.00. Witnessing a positive shift, the current average has risen by 4.6% from the previous average price target of $21.75.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726243292_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Evolus by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Balaji Prasad</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$20.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Serge Belanger</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$22.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Douglas Tsao</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$27.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Serge Belanger</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$22.00</td>
<td>$22.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Evolus. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Evolus compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Evolus's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Capture valuable insights into Evolus's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/EOLS/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Evolus analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Get to Know Evolus Better</h2>
<p>Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.</p>
<h3>Evolus's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> Evolus's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of <strong>35.59%</strong>. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Evolus's net margin is impressive, surpassing industry averages. With a net margin of <strong>-16.96%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>-60.12%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>-4.94%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Evolus's debt-to-equity ratio surpasses industry norms, standing at <strong>6.56</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

EOLS

Analyst Scoreboard: 4 Ratings For Evolus

<p>In the latest quarter, 15 analysts provided ratings for Iris Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $16.53, a high estimate of $26.00, and a low estimate of $9.50. This upward trend is apparent, with the current average reflecting a 3.31% increase from the previous average price target of $16.00.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726243284_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>The perception of Iris Energy by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lucas Pipes</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$12.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Brett Knoblauch</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Chase White</td>
<td>Compass Point</td>
<td>Lowers</td>
<td>Buy</td>
<td>$16.00</td>
<td>$18.50</td>
</tr>
<tr>
<td>Joseph Vafi</td>
<td>Canaccord Genuity</td>
<td>Maintains</td>
<td>Buy</td>
<td>$15.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Paul Golding</td>
<td>Macquarie</td>
<td>Raises</td>
<td>Outperform</td>
<td>$13.50</td>
<td>$12.00</td>
</tr>
<tr>
<td>Brett Knoblauch</td>
<td>Cantor Fitzgerald</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$20.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Mike Colonnese</td>
<td>HC Wainwright &amp; Co.</td>
<td>Lowers</td>
<td>Buy</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Joseph Vafi</td>
<td>Canaccord Genuity</td>
<td>Maintains</td>
<td>Buy</td>
<td>$15.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Reginald Smith</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$9.50</td>
<td>$11.00</td>
</tr>
<tr>
<td>Brett Knoblauch</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$23.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Joseph Vafi</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$15.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Mike Colonnese</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$15.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Lucas Pipes</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$17.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Gautam Chhugani</td>
<td>Bernstein</td>
<td>Announces</td>
<td>Outperform</td>
<td>$26.00</td>
<td>-</td>
</tr>
<tr>
<td>Lucas Pipes</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$18.00</td>
<td>$9.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Iris Energy. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Iris Energy compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Iris Energy's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Capture valuable insights into Iris Energy's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/IREN/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Iris Energy analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Unveiling the Story Behind Iris Energy</h2>
<p>Iris Energy Ltd is a Bitcoin mining company. It builds, owns, and operates data centers and electrical infrastructure for the mining of Bitcoin powered by renewable energy. The company's mining operations generate revenue by earning Bitcoin through a combination of block rewards and transaction fees from the operation of its specialized computers called Application-specific Integrated Circuits and exchanging these Bitcoin for currencies such as USD or CAD on a daily basis.</p>
<h3>Iris Energy's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Iris Energy displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately <strong>70.58%</strong>. This indicates a notable increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Iris Energy's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-46.37%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Iris Energy's ROE excels beyond industry benchmarks, reaching <strong>-3.05%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Iris Energy's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>-2.88%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Iris Energy's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.0</strong>.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


IREN

Beyond The Numbers: 15 Analysts Discuss Iris Energy Stock

<p>In the latest quarter, 11 analysts provided ratings for Unity Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $20.0, along with a high estimate of $33.50 and a low estimate of $10.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 17.29%. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726243272_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive Unity Software. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Parker Lane</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$25.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Matthew Cost</td>
<td>Morgan Stanley</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$22.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Bernie McTernan</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$23.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Tim Nollen</td>
<td>Macquarie</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$12.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Mike Hickey</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Sell</td>
<td>$10.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Kash Rangan</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$22.50</td>
<td>$26.00</td>
</tr>
<tr>
<td>Michael Pachter</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$21.00</td>
<td>$33.50</td>
</tr>
<tr>
<td>Thomas Champion</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$17.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Parker Lane</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$20.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Michael Pachter</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$33.50</td>
<td>$33.50</td>
</tr>
<tr>
<td>Tim Nollen</td>
<td>Macquarie</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$14.00</td>
<td>$20.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Unity Software. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Unity Software compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Unity Software's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Unity Software's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/U/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Unity Software analyst ratings.</strong></a></p>
<h2>Get to Know Unity Software Better</h2>
<p>Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.</p>
<h3>Unity Software: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Unity Software's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately <strong>-15.79%</strong>. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> Unity Software's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of <strong>-27.95%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Unity Software's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>-3.94%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Unity Software's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>-1.87%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> Unity Software's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>0.7</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Expert Ratings For Unity Software

Boeing CFO Says Broadly There Are Real Supply Chain Constraints In The Industry; Supply Chain Constraints Impacting Widebody Deliveries

<p>Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) has outperformed the market over the past 5 years by 3.03% on an annualized basis producing an average annual return of 16.36%. Currently, Fluor has a market capitalization of $7.69 billion. </p>
<p><strong>Buying $100 In FLR:</strong> If an investor had bought $100 of FLR stock 5 years ago, it would be worth <strong>$209.58</strong> today based on a price of $44.90 for FLR at the time of writing.</p>
<h3>Fluor's Performance Over Last 5 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726243260_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today

<p>In the preceding three months, 4 analysts have released ratings for Park Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PK#NYSE">PK</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for Park Hotels &amp; Resorts, presenting an average target of $16.38, a high estimate of $19.00, and a low estimate of $14.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 12.64%. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726243260_0_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive Park Hotels &amp; Resorts. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Dori Kesten</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$14.50</td>
<td>$17.00</td>
</tr>
<tr>
<td>Patrick Scholes</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$18.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Robin Farley</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$14.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Richard Hightower</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$19.00</td>
<td>$20.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Park Hotels &amp; Resorts. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Park Hotels &amp; Resorts compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Park Hotels &amp; Resorts's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PK/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Park Hotels &amp; Resorts analyst ratings.</strong></a></p>
<h2>All You Need to Know About Park Hotels &amp; Resorts</h2>
<p>Park Hotels &amp; Resorts owns upper-upscale and luxury hotels with 23,428 rooms across 39 hotels in the United States. Park also has interests through joint ventures in another 2,665 rooms in four U.S. hotels. Park was spun out of narrow-moat Hilton Worldwide Holdings at the start of 2017, so most of the company's hotels are still under Hilton brands. The company has sold all its international hotels and many of its lower-quality U.S. hotels to focus on high-quality assets in domestic gateway markets.</p>
<h3>Park Hotels &amp; Resorts: A Financial Overview</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Park Hotels &amp; Resorts's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately <strong>-3.92%</strong> in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Park Hotels &amp; Resorts's net margin excels beyond industry benchmarks, reaching <strong>9.33%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>1.69%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Park Hotels &amp; Resorts's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>0.7%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Park Hotels &amp; Resorts's debt-to-equity ratio is below the industry average. With a ratio of <b>1.27</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Park Hotels & Resorts Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

<p>Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) has outperformed the market over the past 20 years by 3.17% on an annualized basis producing an average annual return of 11.52%. Currently, Gilead Sciences has a market capitalization of $102.99 billion. </p>
<p><strong>Buying $100 In GILD:</strong> If an investor had bought $100 of GILD stock 20 years ago, it would be worth <strong>$902.07</strong> today based on a price of $82.72 for GILD at the time of writing.</p>
<h3>Gilead Sciences's Performance Over Last 20 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726243255_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


GILD

$100 Invested In This Stock 20 Years Ago Would Be Worth $900 Today

<p>The average American consumer is more optimistic than expected in September, <a href="https://www.benzinga.com/topic/consumers">data shows</a>. </p>
<p>According to the University of Michigan&#8217;s <a href="https://www.benzinga.com/topic/consumers">September Survey of Consumers</a>, the consumer sentiment index rose to its highest level in four months, surpassing economic estimates. </p>
<p>This surge reflects improvements in both current conditions and future expectations, driven by lower inflation worries and <a href="https://www.benzinga.com/economics/macro-economic-events/24/09/40812986/inflation-slows-to-2-5-in-august-lowest-rate-since-february-2021-core-index-remai">more favorable price conditions.</a></p>
<p><strong>See Also</strong>: <strong><a href="https://www.benzinga.com/news/24/09/40852078/trump-vs-harris-latest-poll-hands-vice-president-5-point-lead-but-heres-why-vetran-pollster-nate-sil">Latest Poll Hands Vice President Harris 5-Point Lead Over Trump</a></strong></p>
<p>Key Highlights:</p>
<ul>
<li>The University of Michigan consumer sentiment index rose from 67.9 August to 69 points in September, marking a 1.6% monthly surge and surpassing economist estimates – as tracked by TradingEconomics – of 68.</li>
<li>The sub-index for consumer expectations increased from 72.1 to 73 points, topping expectations of a decline to 71. </li>
<li>The sub-index for current conditions rose from 61.3 to 62.9, surpassing estimates of 61.5. </li>
<li>The year-ahead inflation expectations fell from 2.8% to 2.7%, the lowest in nearly four years, below forecasts of 2.8%. Long-term inflation expectations inched slightly higher from 3% to 3.1%. </li>
</ul>
<h3 class="wp-block-heading">Economist Takeaways </h3>
<p>&#8220;The gain was led by an improvement in buying conditions for durables, driven by more favorable prices as perceived by consumers. Year-ahead expectations for personal finances and the economy both improved as well, despite a modest weakening in views of labor markets,&#8221; said University of Michigan's Surveys of Consumers Director&nbsp;<strong>Joanne Hsu</strong>.&nbsp;</p>
<p>Consumer sentiment is now roughly 40% higher than its June 2022 low, though caution remains widespread due to uncertainty surrounding the upcoming election, according to the expert.</p>
<p>However, there is contrasting sentiment between Democratic and Republican consumers as <a href="https://www.benzinga.com/topic/election-day">Election Day approaches</a> and Vice President <strong>Kamala Harris</strong> <a href="https://www.benzinga.com/general/politics/24/09/40805945/harris-vs-trump-vice-president-holds-3-point-lead-ahead-of-presidential-debate-but-swing-states-">widens the lead</a> over Ex-President <strong>Donald Trump</strong> <a href="https://www.benzinga.com/news/24/09/40761709/anthony-scaramucci-trump-will-lose-then-start-panicking-over-november-sentencing?itm_source=parsely-api">in preliminary polls</a>.</p>
<p>Hsu highlighted that &#8220;partisan gaps in sentiment inched up,&#8221; amid consumers&#8217; opposing views on the economic <a href="https://www.benzinga.com/startups/24/09/40855223/mark-cuban-praises-kamala-harris-support-for-business-is-her-new-tax-plan-a-game-changer">impact of her potential presidency</a>.</p>
<h3 class="wp-block-heading">Market Reactions</h3>
<p>Stocks extended their gains following the sentiment report. By 10:15 a.m. in New York, the <strong>SPDR S&amp;P 500 ETF Trust</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was up 0.4%, while the tech-focused <strong>Invesco QQQ Trust, Series 1</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) edged 0.2% higher.</p>
<p>Small caps led the rally, with the <strong>iShares Russell 2000 ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) surging 2%. Blue chips, tracked by the <strong>SPDR Dow Jones Industrial Average ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>), rose 0.5%.</p>
<p>All 11 S&amp;P 500 sectors posted gains, with the <strong>Materials Select Sector SPDR Fund</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>) leading the way, up 1%, supported by strength in precious metals.</p>
<p>Meanwhile, the U.S. dollar weakened, with the <strong>Invesco DB USD Index Bullish Fund ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>) slipping 0.4%. The dollar also dropped 0.9% against the Japanese yen, hitting levels last seen in late December 2023.</p>
<p><strong>Now Read:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/asia/24/09/40842879/major-central-banks-slash-rates-in-sync-but-one-holdout-threatens-to-derail-bulls-momentum-carry-tra">Major Central Banks Slash Rates In Sync, But One Holdout Threatens To Derail Bulls&#8217; Momentum: &#8216;Carry Trade Is Still Unwinding&#8217;</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


SPDR Dow Jones Industrial Average ETF Trust

PowerShares DB US Dollar Index Bullish Fund

Consumer Morale Hits 4-Month High, Inflation Expectations Ease: 'Partisan Gaps In Sentiment Inched Up'

<p>Align Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for Align Tech, revealing an average target of $325.0, a high estimate of $350.00, and a low estimate of $310.00. This current average has decreased by 7.07% from the previous average price target of $349.71. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726243234_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>The standing of Align Tech among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jason Bednar</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$315.00</td>
<td>$315.00</td>
</tr>
<tr>
<td>Erin Wright</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$310.00</td>
<td>$328.00</td>
</tr>
<tr>
<td>Jonathan Block</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$350.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>Jason Bednar</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$315.00</td>
<td>$330.00</td>
</tr>
<tr>
<td>Jeff Johnson</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$325.00</td>
<td>$370.00</td>
</tr>
<tr>
<td>Jason Bednar</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$330.00</td>
<td>$330.00</td>
</tr>
<tr>
<td>Jason Bednar</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$330.00</td>
<td>$375.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Align Tech. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Align Tech compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for Align Tech's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Align Tech's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/ALGN/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Align Tech analyst ratings.</strong></a></p>
<h2>Delving into Align Tech's Background</h2>
<p>Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.</p>
<h3>Align Tech: A Financial Overview</h3>
<p><strong>Market Capitalization Analysis:</strong> With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.</p>
<p><strong>Revenue Growth:</strong> Align Tech displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately <strong>2.63%</strong>. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> Align Tech's net margin is impressive, surpassing industry averages. With a net margin of <strong>9.39%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Align Tech's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>2.57%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Align Tech's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>1.57%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.03</strong>.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ALGN

Deep Dive Into Align Tech Stock: Analyst Perspectives (7 Ratings)

<p><strong>Neurocrine Biosciences Inc.&#8217;s</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIX#NASDAQ">NBIX</a>) ERUDITE phase two clinical study of investigational compound luvadaxistat (NBI-1065844) failed to meet its primary endpoint as a potential treatment to improve cognitive <a href="https://www.benzinga.com/pressreleases/24/09/n40842532/neurocrine-biosciences-provides-update-on-erudite-phase-2-data-for-luvadaxistat-in-adults-with-cog" target="_blank" rel="noreferrer noopener">impairment in schizophrenia patients</a>.</p>
<p>It failed to replicate the cognitive endpoint data seen in the earlier INTERACT study due in part to the large variability seen in the cognitive measures across the population studied and a potential imbalance in the baseline characteristics of subjects enrolled across the treatment arms.</p>
<p><strong>Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40632561/neurocrine-biosciences-lower-dose-data-puts-its-schizophrenia-candidate-in-the-game" rel="noreferrer noopener">Neurocrine Biosciences&#8217; Lower Dose Data Puts Its Schizophrenia Candidate In The Game, Analyst Upgrades Stock</a></strong></p>
<p>In the INTERACT study, 50 mg luvadaxistat resulted in a statistically significant improvement in the measure of cognition on the Brief Assessment of Cognition in Schizophrenia (BACS) and cognitive performance on the Schizophrenia Cognition Rating Scale (SCoRS).</p>
<p>The INTERACT study was the first to demonstrate statistical significance for both cognitive measures and function within a single study.</p>
<p>The company stated it was disappointed that luvadaxistat did not meet the primary endpoint in this study and it understood the challenges and hurdles that exist in identifying potential medicines for the treatment of cognitive impairment in schizophrenia.</p>
<p>Neurocrine Biosciences will halt further development of luvadaxistat and instead will focus on the advancement into phase three development of NBI-1117568 for schizophrenia and NBI-1065845 for major depressive disorder.</p>
<p>In August, Neurocrine Biosciences shared topline data for its phase one study of NBI-1117568 (NBI-‘568) in&nbsp;<a href="https://www.benzinga.com/pressreleases/24/08/n40596900/neurocrine-biosciences-reports-positive-phase-2-data-for-nbi-1117568-in-adults-with-schizophrenia" target="_blank" rel="noreferrer noopener">adults with schizophrenia</a>.</p>
<p>The new data showed that the once-daily 20 mg dose of NBI-‘568 induced an average 18.2-point reduction from baseline in the Positive and Negative Syndrome Scale (PANSS) after six weeks, compared to 10.8 <a target="_blank" href="https://www.benzinga.com/general/biotech/24/08/40604853/as-regulators-gear-up-to-decide-on-bristol-myers-schizophrenia-treatment-neurocrine-biosciences-d" rel="noreferrer noopener">points in the placebo group</a>.</p>
<p>William Blair noted further value can be unlocked through the expanding Ingrezza business, the anticipated near-term launch of crinecerfont for treating congenital adrenal hyperplasia (CAH), with PDUFA dates set for Dec. 29 and 30, 2024, and the company's mid-stage portfolio.</p>
<p>The analyst reiterated the Outperform <a href="https://www.benzinga.com/quote/NBIX/analyst-ratings" target="_blank" rel="noreferrer noopener">rating on Neurocrine</a>.</p>
<p><strong>NBIX</strong> <strong>Price Action: </strong>Neurocrine Biosciences stock is up 0.82% at $122.27 at last check Friday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/m-a/24/09/40853165/sony-eyes-500m-deal-for-pink-floyds-iconic-music-catalog-report" target="_blank" rel="noreferrer noopener">Sony Eyes $500M Deal for Pink Floyd&#8217;s Iconic Music Catalog: Report</a>.</strong></li>
</ul>
<p><em>Photo: Romix Image via Shutterstock</em></p>


Analyst Color

Large Cap

Health Care

Reiteration

NBIX

Neurocrine Shifts Focus To New Schizophrenia Treatment After Luvadaxistat Trial Misses Endpoint

<p>CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $33.2, a high estimate of $38.00, and a low estimate of $29.00. This current average reflects an increase of 8.5% from the previous average price target of $30.60. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726243227_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>The analysis of recent analyst actions sheds light on the perception of CNO Finl Group by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$37.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Thomas Gallagher</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Underperform</td>
<td>$29.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$38.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Ryan Krueger</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$31.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$31.00</td>
<td>$29.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CNO Finl Group. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of CNO Finl Group compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of CNO Finl Group's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into CNO Finl Group's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CNO/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on CNO Finl Group analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind CNO Finl Group</h2>
<p>CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.</p>
<h3>Breaking Down CNO Finl Group's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, CNO Finl Group showcased positive performance, achieving a revenue growth rate of <strong>4.24%</strong> as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> CNO Finl Group's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>10.91%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>4.85%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> CNO Finl Group's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>0.33%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>1.86</strong>, caution is advised due to increased financial risk.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Scoreboard: 5 Ratings For CNO Finl Group

<p>Piper Sandler  analyst Thomas Champion   reiterates Pinterest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>) with a Overweight and maintains $45 price target.</p>


Price Target

PINS

Piper Sandler Reiterates Overweight on Pinterest, Maintains $45 Price Target

<p>Barclays  analyst Balaji Prasad   maintains Evolus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOLS#NASDAQ">EOLS</a>) with a Overweight and raises the price target from $16 to $20.</p>


Barclays Maintains Overweight on Evolus, Raises Price Target to $20

<p>Piper Sandler  analyst John Barnidge   reiterates CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) with a Overweight and maintains $37 price target.</p>


Piper Sandler Reiterates Overweight on CNO Finl Group, Maintains $37 Price Target

<p><a href="https://www.globenewswire.com/Tracker?data=rQIIKx5Wn_ZqqJECqHVXs0_vgzhKenBXyrBv6nMxiqesmzixkv0EBZBAl5gNmqrXZUBnLOJ5jDgwhSrbP4CeNEZ2qetzp6CkxDeL13sV6Tw=">Mullen Automotive Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) ("Mullen" or the "Company"), an electric vehicle ("EV") manufacturer, announced today that it will effect a 1-for-100 reverse stock split ("Reverse Stock Split") of its common stock, par value $0.001 per share ("Common Stock"), that will become effective on Sept. 17, 2024, at 12:01 a.m. Eastern Time. The Common Stock will continue to trade on The Nasdaq Capital Market ("Nasdaq") under the existing symbol MULN and will begin trading on a split-adjusted basis when the market opens on Sept. 17, 2024. The new CUSIP number for the Common Stock following the Reverse Stock Split will be 62526P505.</p>
<p>The Reverse Stock Split is primarily intended to bring the Company into compliance with the $1.00 minimum bid price requirement for maintaining its listing on Nasdaq. There is no guarantee the Company will meet the minimum bid price requirement.</p>


Stock Split

MULN

Mullen Automotive Announces 1-For-100 Reverse Stock Split Effective Sept. 17, 2024

<p><a href="https://www.benzinga.com/real-estate/24/05/39116410/grant-cardone-slams-nyc-after-trump-verdict-i-will-never-do-business-in-new-york-city">Grant Cardone</a>, the well-known real estate mogul, recently revealed a hard truth about his finances that might surprise some. Despite earning returns of 5.5%, he claims he&#8217;s losing money. How is this possible? In a candid interview with VladTV, Cardone said it all comes down to taxes and inflation.</p>
<p><strong>Don't Miss:</strong></p>
<ul>
<li><strong>The average American couple has saved this much money for retirement —</strong><a href="http://www.benzinga.com/money/smartasset"><strong> </strong><strong>How do you compare</strong></a><strong>?</strong></li>
<li><strong>Founder of Personal Capital and ex-CEO of PayPal</strong><a href="https://www.benzinga.com/money/evergreen-money"><strong> </strong><strong>re-engineers traditional banking with this new high-yield account — start saving better today.</strong></a></li>
<li><strong>The number of ‘401(k)' Millionaires is up 43% from last year —</strong><a href="https://www.benzinga.com/money/401k-millionaires"><strong> </strong><strong>Here are three ways to join the club.</strong></a></li>
</ul>
<p>He explained how a large portion of his fortune – around $500 million – has been sitting in a sweep account at a bank. That money is essentially his &#8220;dry powder,&#8221; a reserve he's holding onto for future real estate deals. But while the cash waits, it's steadily losing its value. Cardone admitted, "I didn't keep up with the hammering," referring to how inflation and taxes have eroded the worth of his savings.</p>
<p><strong>Trending:</strong> <strong>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." </strong><a href="https://www.benzinga.com/money/connect-invest-real-estate-notes"><strong>These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</strong></a></p>
<p>Earning 5.5% may sound decent, but it's far from a win for Cardone. &#8220;I don't want 5% on my money,&#8221; he said. After taxes, the returns shrink significantly. "That's all taxed at my rate," he pointed out, meaning that after the government takes its slice, his real return is closer to 2.7%. That's the problem – those earnings aren&#8217;t enough to keep up with inflation. He said bluntly, "I'm actually losing money by keeping it there."</p>
<p>Inflation in the U.S. has been creeping up, averaging about 3% annually. So even if Cardone's cash earns 5.5%, by the time taxes and inflation have their say, he&#8217;s coming out on the losing end.&nbsp;</p>
<p><strong>Trending:</strong> <strong>The startup behind White Castle's favorite Robot Fry Cook announces a next-generation fast food robot – </strong><a href="https://www.benzinga.com/money/miso-robotics-flippy"><strong>Here's how to get a share for under $5 today.</strong></a></p>
<p>And Cardone's not alone. Even financial heavyweights like Warren Buffett face the same dilemma. Buffett reportedly holds an eye-popping $189 billion in cash and it's all losing purchasing power thanks to inflation.</p>
<p>Buffett has spoken about this, calling inflation a "far more devastating tax" than any formal legislation. And he&#8217;s not wrong. Inflation quietly eats away at wealth and it&#8217;s something that all investors – whether mega-rich or just starting – have to grapple with. So, how do some of the savviest investors fight against this invisible tax?</p>
<p><strong>Trending: Can you guess how many retire with a $5,000,000 nest egg? &#8211;</strong><a href="https://www.benzinga.com/money/retire-5mil-nest-egg"><strong> </strong><strong>How does it compare to the average?</strong></a></p>
<p>For Cardone, the answer has always been real estate. It&#8217;s no secret that real estate tends to hold its value, even when inflation rises. Property prices and rent are tied to the cost of living, which means when everything else gets more expensive, real estate does, too.&nbsp;</p>
<p>Analysis from Avison Young shows a clear link between real estate returns and inflation, especially when properties are held long-term. For investors, this is a way to maintain wealth while inflation is at its worst.</p>
<p>Buffett, on the other hand, prefers to bet on strong companies. He argues that solid businesses with pricing power can simply raise their prices in line with inflation, passing the cost on to customers. The numbers seem to back him up.&nbsp;</p>
<p><strong>Trending: These five entrepreneurs are worth $223 billion –</strong><a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"><strong> </strong><strong>they all believe in one platform that offers a 7-9% target yield with monthly dividends</strong></a></p>
<p>According to Charlie Billelo of Creative Planning, the S&amp;P 500 – adjusted for inflation – has delivered an impressive 840% return since 1994. Over that same time, the value of the U.S. dollar dropped by over 50%.</p>
<p>Then there's gold. It's long been seen as a hedge against <a href="https://www.benzinga.com/real-estate/24/09/40818098/grant-cardones-inflation-breakdown-40-energy-cost-hike-marks-biden-harris-economic-impact">inflation</a>, with central banks worldwide holding precious metal reserves to maintain stability. Some investors, like billionaire Ray Dalio, turn to gold when worried about rising inflation and government debt. But not everyone's sold on gold's role as an inflation hedge.&nbsp;</p>
<p>A Reuters study found that only 16% of gold's price movements since 1971 are linked to inflation and some experts argue that its inflation-adjusted value has fallen since 1980.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong>How do billionaires pay less in income tax than you?</strong><a href="https://www.benzinga.com/money/tax-deferring-adv"><strong> </strong><strong>Tax deferring is their number one strategy</strong></a><strong>.</strong></li>
<li><strong>Warren Buffett flipped his neighbor's $67,000 life savings into a $50 million fortune —</strong><a href="https://www.benzinga.com/money/advisor-adv-warren-buffett"><strong> </strong><strong>How much is that worth today?</strong></a></li>
</ul>


Personal Finance

Grant Cardone Reveals How His 5.5% Returns Are Actually Costing Him Money – Why He Says You're Still Losing Money

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our<a href="http://benzinga.com/analyst-stock-ratings"> analyst ratings page</a>.</p>
<ul>
<li>Wells Fargo cut the price target for<strong> Pebblebrook Hotel Trust </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEB#NYSE">PEB</a>) from $15 to $13. Wells Fargo analyst Dori Kesten maintained an Equal-Weight rating. Pebblebrook Hotel Trust shares rose 1.5% to trade at $12.98 on Friday. S<a href="https://www.benzinga.com/quote/PEB/analyst-ratings">ee how other analysts view this stock.</a></li>
<li>TD Cowen cut the price target for <strong>Moderna, In</strong>c. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) from $70 to $60. TD Cowen analyst Tyler Van Buren maintained a Hold rating. Moderna shares fell 4.9% to trade at $66.25 on Friday. <a href="https://www.benzinga.com/quote/mrna/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Truist Securities cut <strong>Zimmer Biomet Holdings, Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZBH#NYSE">ZBH</a>) price target from $117 to $112. Truist Securities analyst Richard Newitter reiterated a Hold rating. Zimmer Biomet shares gained 1.8% to trade at $107.06 on Friday. <a href="https://www.benzinga.com/quote/zbh/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Guggenheim raised <strong>Oracle Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) price target from $185 to $200. Guggenheim analyst John Difucci maintained a Buy rating. Oracle shares rose 1% to trade at $162.87 on Friday. <a href="https://www.benzinga.com/quote/orcl/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs raised the price target for <strong>TPG Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) from $53 to $60. Goldman Sachs analyst Alexander Blostein maintained a Buy rating. TPG shares gained 3% to close at $55.55 on Friday. S<a href="https://www.benzinga.com/quote/tpg/analyst-ratings">ee how other analysts view this stock</a>.</li>
<li>UBS boosted <strong>CubeSmart </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBE#NYSE">CUBE</a>) price target from $53 to $54. UBS analyst Michael Goldsmith downgraded the stock from Buy to Neutral. CubeSmart shares fell 0.2% to trade at $53.81 on Friday. <a href="https://www.benzinga.com/quote/cube/analyst-ratings">See how other analysts view this stoc</a>k.</li>
<li>Stifel cut <strong>Wynn Resorts, Limite</strong>d (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>) price target from $121 to $103. Stifel analyst Steve Wieczynski maintained a Buy rating. Wynn Resorts shares rose 3.6% to trade at $79.07 on Friday. <a href="https://www.benzinga.com/quote/wynn/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Citigroup cut the price target for <strong>Nabors Industries Ltd</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBR#NYSE">NBR</a>) from $110 to $75. Citigroup analyst Scott Gruber downgraded the stock from Buy to Neutral. Nabors Industries shares rose 0.5% to trade at $65.41 on Friday. <a href="https://www.benzinga.com/quote/nbr/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays slashed <strong>Garmin Ltd</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRMN#NYSE">GRMN</a>) price target from $181 to $133. Barclays analyst George Wang downgraded the stock from Equal-Weight to Underweight. Garmin shares fell 6.2% to trade at $170.74 on Friday. <a href="https://www.benzinga.com/quote/grmn/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Evercore ISI Group raised <strong>The Kroger Co</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) price target from $62 to $63. Evercore ISI Group analyst Michael Montani maintained an Outperform rating. Kroger shares rose 1.1% to trade at $55.81 on Friday. <a href="https://www.benzinga.com/quote/kr/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
<p><strong>Read More:</strong></p>
<ul>
<li><strong> <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/40853112/ionq-is-losing-too-much-money-while-this-tech-stock-is-real-deal-jim-cramer">IonQ Is Losing &#8216;Too Much Money&#8217; While This Tech Stock Is &#8216;Real Deal&#8217;: Jim Cramer</a></strong></li>
</ul>


Markets

CUBE

GRMN

MRNA

ORCL

WYNN

Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>If there&rsquo;s anything I&rsquo;ve learned from years of covering the market, it&rsquo;s that Wall Street loves <a href="https://investorplace.com/stock-types/growth-stocks/">growth stocks</a>. Fast-growing companies tend to attract investor attention and deliver stellar returns relative to value stocks. However, the real Wall Street darlings are companies that can deliver both high growth and solid profits. These rare companies have pricing power, expand margins over time, and eventually start returning excess capital to shareholders, sending their stocks soaring.</p>



<p>In my experience, some of the best opportunities come from under-the-radar growth stocks that are expanding rapidly, yet remain unknown to mainstream investors. With the right fundamentals, these growth stocks can deliver outsized returns and recover quickly during market downturns as they march steadily toward consistent profitability. Let&rsquo;s take a look at three such growth stocks!</p>



<h2>Cematrix (CTXXF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/09/concrete-rain-1600-300x169.jpg" alt="A photograph of rain droplets on a concrete surface."><div>Source: ReneBittner / Shutterstock.com</div></div><p><strong>Cematrix</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/ctxxf-stock-quote/"><strong>CTXXF</strong></a>) is a Canadian company focused on manufacturing and supplying cellular concrete products in North America. These products serve as lightweight backfill for walls, insulation material for oil and gas infrastructure, and grout for various construction purposes. The enterprise can benefit substantially from the construction boom in North America.</p>



<p>Although still a small Canadian firm, I believe the company&rsquo;s upside potential warrants more attention. In fact, CTXXF stock has already been rebounding nicely, up 88% over the past year, but still 59% below its 2021 peak. A stock price of 24 cents per share still appears attractive to me. The company attained profitability in Q3, with <a href="https://www.google.com/finance/quote/CTXXF:OTCMKTS">revenue surging 76% to CAD$20.4 million</a>. I anticipate revenue to potentially double over the coming two years, alongside considerable margin expansion.</p>



<p>Cematrix recently publicized a new CFO and <a href="https://seekingalpha.com/news/4076514-cematrix-announces-new-contracts-worth-67m">$6.7 million in new contracts</a> this month, which could drive substantial growth ahead. With the right execution and strategy, I foresee this cement company becoming a major player in the North American construction materials industry.</p>



<h2>SmartRent (SMRT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/11/smart_home_a_1600-300x169.jpg" alt="A hand holds a smart phone up with a fancy living room behind it."><div>Source: zhu difeng / ShutterStock.com</div></div><p><strong>SmartRent</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/smrt-stock-quote/"><strong>SMRT</strong></a>) is a smart home automation company. It is becoming popular with landlords and homeowners with smart homes. I believe substantial upside potential lies ahead, as the stock trades sideways after declining in late 2021. Rents and housing prices continue rising alongside income, which will only drive more revenue and net income for the company over the long-run. Indeed, the company&rsquo;s financials already appear poised for a turnaround. <a href="https://www.google.com/finance/quote/SMRT:NYSE">Revenue grew 49% year-over-year to $60.3 million</a>, as profitability quickly comes into focus.</p>



<p>Analysts anticipate profits in 2025 accompanied by revenue expanding around 15%-20% annually moving forward. Revenue is expected to surge from <a href="https://seekingalpha.com/symbol/SMRT/earnings/estimates">$273 million in 2024 to $536 million in 2028</a>. The company also possesses $215 million in cash against virtually no debt, providing funds to fuel substantial growth ahead. Moreover, the premium investors pay for exposure to this growth stock seems quite reasonable, at only 2-times forward sales, while <a href="https://investorplace.com/industries/technology/software/">software stocks</a> typically trade at much steeper premiums. If SmartRent manages to surpass its earnings targets going forward, I expect SMRT stock to be one of the best-performing growth stocks in this current cycle.</p>



<h2>DLocal (DLO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/10/smartphone-mobile-financial-fintech-1600-300x169.jpg" alt="Illustration of phone with dollar sign and other graphics symbolizing fintech displayed on and around it, with a blue background. Fintech Stock Bargains"><div>Source: shutterstock.com/ZinetroN</div></div><p><strong>DLocal</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/dlo-stock-quote/"><strong>DLO</strong></a>) is an Uruguayan financial technology firm specializing in cross-border payments. The company&rsquo;s platform links global merchants to emerging markets, enabling receipt of payments from customers and making payments to customers in these regions.</p>



<p>This is another stock that&rsquo;s basically moved sideways over the past year and a half after an initial decline following the post-COVID boom cool-down. My bull case is that substantial growth lies ahead for this fintech stock, which boasts some of the most robust margins in the market &ndash; <a href="https://www.gurufocus.com/stock/DLO/summary">a 23% net margin, exceeding 93% of software industry peers</a>. Its 3-year revenue growth rate sits at 82%, better than 97% of peers. This growth is due to the company&rsquo;s foothold in many fast-growing developing markets.</p>



<p>Moreover, analysts anticipate the company&rsquo;s <a href="https://seekingalpha.com/symbol/DLO/earnings/estimates">earnings per share will double from 2024 to 2026</a>, as revenue surges from $886 million to $1.52 billion over the same period. Paying just 24-times forward earnings for this growth seems like a steal. DLocal also carries virtually no debt, while holding $639 million of cash on its balance sheet. If execution remains solid, I expect substantial upside for long-term investors.</p>



<h2>Freee KK (FREKF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/cloud1600-300x169.jpg" alt="an image of a cloud imprinted on a circuit board lit up by blue circuit lights"><div>Source: Shutterstock</div></div><p><strong>Freee KK</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/frekf-stock-quote/"><strong>FREKF</strong></a>) is a developer of cloud-based software, including Cloud Accounting, Cloud HR Labor, and Cloud ERP products. This Japanese company has been expanding rapidly in recent quarters, and I believe ample growth remains. <a href="https://www.gurufocus.com/term/rvn_growth_3y/FREKF/3-Year-Revenue-Growth-Rate-Per-Share/Freee-KK">The 3-year annual revenue growth rate sits around 30%</a>, and forward 3-5-year annual revenue growth should linger around the same pace.</p>



<p>The major issue is profitability. Freee KK <a href="https://www.google.com/finance/quote/FREKF:OTCMKTS">reported a -67.4% net margin</a> in Q4, which is quite concerning. However, the company possesses $219 million in cash against only $23 million in debt, sufficient to handle more than two years of losses if they remain constant, which is unlikely. I expect losses to begin falling as the company&rsquo;s top line expands.</p>



<p>Also of note, while Japan has exited its negative interest rate policy, rates are still super low, and any cash crunch could easily be supplemented with leverage thanks to the company&rsquo;s minuscule debt burden. This allows more debt intake going forward, so I view FREKF stock as a promising cloud play for the long-run. <em>Gurufocus </em>estimates the stock&rsquo;s fair price at $43.40 in mid-2025, providing major upside from the current $23 per share price tag, if achieved.</p>



<h2>D2L (DTLIF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/online-education-1600-300x169.jpg" alt="man in headphones writing notes in notebook watching webinar video course"><div>Source: fizkes / Shutterstock.com</div></div><p><strong>D2L</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/dtlif-stock-quote/"><strong>DTLIF</strong></a>) is a global learning innovation firm aiming to reshape education and work by pioneering personalized learning and expanding access to high-quality education regardless of age, ability, or location. Millions worldwide use the company&rsquo;s core technology, including the Brightspace LMS.</p>



<p>The stock has been extremely volatile since going public two years ago. However, recent momentum seems promising. Over the past year, DTLIF stock is up around 44%, and I believe it can continue cruising higher. Online learning continues to grow even without pandemic tailwinds, with many still opting to learn remotely.</p>



<p>The company recently posted 11% year-over-year revenue growth alongside <a href="https://www.google.com/finance/quote/DTLIF:OTCMKTS">shrinking losses, which declined from $97.7 million in 2022 to $18.4 million in 2023</a>. That&rsquo;s impressive progress. I think D2L can quickly expand margins and continue double-digit top-line growth. Analysts agree, expecting the company&rsquo;s <a href="https://seekingalpha.com/symbol/DTLIF/earnings/estimates">revenue to hit $452 million in FY2032</a>. With substantial room for margin growth, I see plenty of upside potential if execution remains solid. Notably, D2L also holds $123 million in cash against only $12.6 million in debt.</p>



<h2>Inter &amp; Co. (INTR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/brazil1600a-300x169.jpg" alt="The Brazilian flag with the sun in the background"><div>Source: Shutterstock</div></div><p>As I have articulated numerous times, the economic downturn stemming from interest rate hikes has not been isolated to just banks. It has also detrimentally impacted fintech firms and enterprises relying on the banking industry for growth. However, this narrative does not apply universally. </p>



<p>Brazil is one nation that commenced its rate hike cycle early and has subdued inflation, now entering a rate reduction period. This has been advantageous for the country&rsquo;s fintech and banking sectors, with many Brazil-based fintech companies thriving. One relatively unknown name is <strong>Inter &amp; Co</strong>. (NASDAQ:<a href="https://investorplace.com/stock-quotes/intr-stock-quote/"><strong>INTR</strong></a>), which has gained 265% over the past year. I believe substantial upside remains in the years ahead, as its stellar performance is likely to continue.</p>



<p>Inter &amp; Co. is the holding company of Grupo Inter, operating the premier Super App in the Americas. The company offers banking capabilities, investments, credit, insurance, and cross-border solutions. </p>



<p>Revenue is <a href="https://seekingalpha.com/symbol/INTR/earnings/estimates">anticipated to continue expanding at a double-digit pace</a> in the forthcoming years. Additionally, robust earnings per share growth of 43% is expected in 2025 and 26% in 2026. Paying merely 15-times forward earnings for such growth still appears to be an attractive proposition. Analysts see Inter &amp; Co. delivering $1.24 billion in revenue in 2024 coupled with 40 cents in earnings per share.</p>



<h2>Network-1 Technologies (NTIP)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/01/hand-growth-stocks-1600-300x169.jpg" alt="Hand pointing up and to the right with blue arrow, symbolizes growth stocks. hypergrowth stocks"><div>Source: shutterstock.com/Lemonsoup14</div></div><p><strong>Network-1 Technologies</strong> (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ntip-stock-quote/"><strong>NTIP</strong></a>) specializes in intellectual property development and monetization. The company collaborates with patent holders to assist in licensing their innovations. Significantly, the company&rsquo;s &lsquo;930 patent (6,218,930) plays a crucial role in the industry-standard Power over Ethernet (PoE) technology. </p>



<p>This stock has not been as fortunate as the others on the list. That may be partly due to the fact that Network-1 is one of the more boring stocks when you zoom out. This stock has traded between $2 and $5 per share since 2017, and lingered near the lower end of that band for much of its history.</p>



<p>However, what entices me about this stock is that the small firm still furnishes a dividend with a 4.8% yield, likely because of its impressive 25.4% net income margin. It has negligible debt and <a href="https://seekingalpha.com/symbol/NTIP">$45 million in cash</a>. If the enterprise can utilize its substantial patent portfolio moving forward and leverage it to accelerate growth, I believe substantial upside lies ahead. It is also trading near its $2 floor. So, I view the stock&rsquo;s downside risk as relatively minimal. </p>



<p><strong><a href="https://investorplace.com/stock-types/penny-stocks/">Penny Stocks</a></strong></p>



<p><strong><em>On Penny Stocks and Low-Volume Stocks:</em></strong><em>&nbsp;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&nbsp;<a href="http://investorplace.com/" target="_blank">InvestorPlace.com</a>&rsquo;s writers disclose this fact and warn readers of the risks.</em></p>



<p><em>Read More:&nbsp;Penny Stocks &mdash;&nbsp;</em><a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/"><em>How to Profit Without Getting Scammed</em></a></p>



<p><em>On the date of publication, Omor Ibne Ehsan did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines.</a></em></p>
<div><p>Omor Ibne Ehsan is a writer at InvestorPlace. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks. You can follow him on <a href="https://www.linkedin.com/in/omor-ibne-ehsan-56068022b/">LinkedIn</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/03/7-monster-growth-stocks-to-turn-7k-into-70k/">7 Monster Growth Stocks to Turn $7K into $70k</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

7 Monster Growth Stocks to Turn $7K into $70k

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><a href="https://investorplace.com/stock-types/growth-stocks/">Growth stocks</a> have been on a wild ride for the past few years. The pandemic sent many soaring to unbelievable heights. Then, rising rates and recession fears brought them crashing back to earth. But I believe the growth stock story is far from over. In fact, with the Fed now signaling rate cuts are on the horizon, I think growth stocks are poised for an epic comeback.</p>



<p>Sure, many growth names are still quite risky. Chasing the latest meme stock or unproven biotech is a good way to lose your shirt. However, for investors with a long-term mindset, now is the perfect time to start building positions in high-quality growth stocks.</p>



<p>As rates come down and the economy stabilizes, these businesses could deliver explosive returns. I wouldn&rsquo;t be surprised to see some of the best growth stocks 5X or more in value over the next five years. Of course, you have to be selective and manage your risk. But if you&rsquo;re aiming for outsized gains, having some exposure to growth is a must. Here are seven growth stocks that have the potential to be mega-winners.</p>



<h2>Cadeler (CDLR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/01/money-bag-growth-stocks-1600-300x169.jpg" alt="Graphic of yellow money bag next to green arrow and coins floating in air, symbolizing growth stocks"><div>Source: shutterstock.com/Monster Ztudio</div></div><p><strong>Cadeler</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/cdlr-stock-quote/"><strong>CDLR</strong></a>) installs and maintains offshore wind farms with its fleet of specialized vessels. These massive turbines out at sea generate more consistent power than their land-based counterparts without noise complaints. Cadeler seems perfectly positioned to ride this wave of clean energy expansion.</p>



<p>Analysts project the company&rsquo;s revenue to <a href="http://seekingalpha.com/symbol/CDLR/earnings/estimates" target="_blank">surge from $255 million </a>in 2024 to over $1 billion by 2027. Earnings per share is expected to skyrocket from just 20 cents to $1.86 in that same period. With numbers like these, I wouldn&rsquo;t be surprised to see Cadeler&rsquo;s stock deliver 5x returns or more.</p>



<div><a href="https://investorplace.com/wp-content/uploads/2024/07/chart-67.png"><img width="1200" height="628" src="https://investorplace.com/wp-content/uploads/2024/07/chart-67.png" alt="Growth stocks: Cadeler Revenue EBIT Estimates"><br>Click to Enlarge</a><div>Source: Chart courtesy of <a href="https://GuruFocus.com">GuruFocus.com</a></div></div><p>The company keeps racking up new contracts, too. They recently inked a deal with <strong>Orsted</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/dnngy-stock-quote/"><strong>DNNGY</strong></a>) for a long-term vessel lease starting in 2027.</p>



<p>Of course, I have to temper my enthusiasm with a dose of realism. Cadeler operates in a capital-intensive industry with plenty of risks. Weather delays, project cancellations, or new competitors could throw a wrench in their plans. But from where I&rsquo;m sitting, the potential rewards far outweigh the risks for this offshore wind pure-play.</p>



<h2>Megaport (MGPPF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/10/growthstocks_1600_02-300x169.jpg" alt="Hand of woman watering small plant in pot shaped like growing graph representing growth stocks. Sleeper Growth Stocks"><div>Source: Khakimullin Aleksandr / Shutterstock</div></div><p><strong>Megaport</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/mgppf-stock-quote/"><strong>MGPPF</strong></a>) operates a global software-defined network platform that enables businesses to connect their networks to cloud services and data centers. Thanks to the AI revolution, the data center industry is booming and this trend will only accelerate in the coming years. Megaport is perfectly positioned to ride this wave of growth.</p>



<p>Megaport reported impressive numbers. <a href="https://markets.businessinsider.com/news/stocks/australian-stocks-megaport-shares-fall-as-upgraded-forecast-disappoints-1033299336" target="_blank">Revenue increased 30% </a>year-over-year to 49.5 million AUD, while EBITDA nearly doubled to 14 million AUD. The company also upgraded its full-year EBITDA guidance.</p>



<p>Despite these strong results, Megaport&rsquo;s stock price took a hit recently. Regardless, this company is profitable and growing rapidly, with plenty of runway ahead as the data center and AI industries continue to expand.</p>



<p>Sure, there are risks to consider. Megaport&rsquo;s success hinges on sustained growth in AI and data center demand. But given the massive investments pouring into these sectors, I&rsquo;m optimistic about the company&rsquo;s prospects.</p>



<h2>Ouster (OUST)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/growth-confidence-300x169.png" alt="An image of a man relaxing, sleeping on a stock growth chart; growth stocks"><div>Source: eamesBot / Shutterstock</div></div><p><strong>Ouster</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/oust-stock-quote/"><strong>OUST</strong></a>) makes high-resolution digital lidar sensors for autonomous vehicles, robotics and smart infrastructure. This company is poised to ride the massive robotics and automation adoption wave in the coming years. The lidar industry could surge as companies across sectors embrace these technologies, and Ouster seems uniquely positioned to capitalize. Their recent financial performance has been stellar compared to lidar peers. It is still unprofitable, but analysts project Ouster could reach profitability by 2027 with significant growth after that. If analyst estimates pan out, you&rsquo;re looking at just 3x 2027 earnings at current prices.</p>



<p>Of course, it&rsquo;s speculative at this stage. But I see multibagger potential here if robotics continues its exponential growth and EVs come back with increased lidar usage. The stock has surged lately on strong Q1 results, with <a href="https://finance.yahoo.com/news/ouster-announces-record-revenue-margin-201500186.html" target="_blank">revenue up 51% year-over-year to $26 million</a>. Several analysts have boosted price targets, including Craig-Hallum to $13 and Rosenblatt to $17.</p>



<h2>ClearPoint Neuro (CLPT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/05/brain-400x225-1-300x169.png" alt="A concept image of a glowing blue brain to depict AI"><div>Source: Andrus Ciprian / Shutterstock.com</div></div><p><strong>ClearPoint Neuro</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/clpt-stock-quote/"><strong>CLPT</strong></a>) makes platforms for performing minimally invasive surgical procedures in the brain. CLPT stock has surged about 40% in the past two weeks and could climb even higher if the company maintains its growth trajectory and continues making medical breakthroughs. </p>



<p>While I typically steer clear of small biotech firms, I think it is worth considering CLPT. I&rsquo;m personally quite bullish on gene-editing companies. These cutting-edge businesses have the potential to cure a wide array of diseases and boast extensive pipelines. This optimism extends to ClearPoint Neuro as well.</p>



<p>In Q1, <a href="https://www.investing.com/news/stock-market-news/earnings-call-clearpoint-neuro-sees-robust-q1-growth-with-diverse-revenue-streams-93CH-3430774" target="_blank">revenue rose 41% year-over-year</a> to $7.6 million. That&rsquo;s not too bad, considering this top-line number beat estimates by 9.23%. It still trades at quite a steep sales premium, but I see multiple catalysts on the horizon that could keep sales growing fast.</p>



<p>Cash is also one of the most important metrics for an unprofitable biotech company. This company&rsquo;s cash holdings are around $35 million, which is satisfactory considering its $4.15 million in net losses in Q1.</p>



<h2>Block (SQ)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/03/sq-block-1600-300x169.png" alt="Square, Inc. changes name to Block (SQ). Smartphone with Square logo on screen in hand on background of Block logo."><div>Source: Sergei Elagin / Shutterstock.com</div></div><p><strong>Block</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/sq-stock-quote/"><strong>SQ</strong></a>) is much more than just a <strong>PayPal</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/pypl-stock-quote/"><strong>PYPL</strong></a>) alternative as it has been in the past. It has delivered impressive financial results recently, with <a href="https://www.cnbc.com/2024/05/02/block-sq-earnings-q1-2024.html" target="_blank">Q1 2024 revenue of $5.96 billion</a> beating estimates and adjusted EPS of 85 cents, surpassing expectations. Block raised its full-year 2024 guidance, now expecting gross profit of at least $8.78 billion (17% growth) and adjusted operating income of at least $1.3 billion. If we look at fundamentals, this stock should&rsquo;ve recovered to around $100 many months ago, but the broader fintech industry has not been cooperating.</p>



<div><a href="https://investorplace.com/wp-content/uploads/2024/07/chart-68.png"><img width="1200" height="628" src="https://investorplace.com/wp-content/uploads/2024/07/chart-68.png" alt="Block EPS revenue estimates"><br>Click to Enlarge</a><div>Source: Chart courtesy of <a href="https://GuruFocus.com">GuruFocus.com</a></div></div><p>That said, analysts are now projecting EPS to <a href="https://seekingalpha.com/symbol/SQ/earnings/estimates" target="_blank">increase from $3.4 in 2024 to $15 by 2033</a> &mdash; and it is expected to double from 2024 by 2028. Block&rsquo;s stock has been trading sideways at a discounted level due to the depressed fintech sector; rising EPS should lead to an eventual breakout.</p>



<p>Moreover, impending interest rate cuts could also catalyze a major rally for Block. Block could deliver 5x returns in five years if the market fully appreciates its profitable growth. Management would need to surpass those optimistic EPS expectations I mentioned above. Can they do it? That&rsquo;s for you to bet on.</p>



<h2>Fastly (FSLY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/07/fsly-stock-1-300x169.jpg" alt="A magnifying glass zooms in on the Fastly (FSLY) website."><div>Source: Pavel Kapysh / Shutterstock.com</div></div><p><strong>Fastly</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/fsly-stock-quote/"><strong>FSLY</strong></a>) operates a content delivery network that enables faster and more reliable delivery of digital content. Fastly is an exciting bet on the future of cloud computing, edge computing and streaming over the next five years. Yes, the stock has plummeted nearly 58% in the past year amid concerns over slowing growth and mounting losses. However, shares have stabilized recently, and Fastly could deliver outsized returns.</p>



<p>Analysts seem cautiously optimistic, with an <a href="https://www.tipranks.com/stocks/fsly/forecast" target="_blank">average price target of $9.8</a>, implying a 29% upside from current levels. The company also reported solid Q1 results, with <a href="https://www.investing.com/news/company-news/fastly-cfo-sells-shares-worth-over-87000-93CH-3508018" target="_blank">revenue up 14% year-over-year to $133.5 million</a>, beating estimates.</p>



<p>Looking ahead, Fastly is expected to turn profitable in 2025. You are currently paying <a href="https://seekingalpha.com/symbol/FSLY/earnings/estimates" target="_blank">just four times 2030 earnings</a>, though I will warn again that these estimates are very speculative.</p>



<p>Regardless, the risk-reward looks favorable for people willing to ride out the volatility. Cloud and edge computing are clear megatrends that should provide strong long-term tailwinds for Fastly&rsquo;s business.</p>



<h2>freee K.K. (FREKF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/03/brokerageaccount1600-300x169.jpg" alt="A pile of $100 bills on a black background with a smartphone displaying a stock chart on top."><div>Source: etonastenka / Shutterstock.com</div></div><p><strong>freee K.K.</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/frekf-stock-quote/"><strong>FREKF</strong></a>) specializes in delivering cloud-based accounting and HR software solutions to small and medium-sized businesses in Japan. This company is poised for hypergrowth as more Japanese companies rush to digitize their back-office operations. In fact, freee&rsquo;s <a href="https://www.google.com/finance/quote/FREKF:OTCMKTS" target="_blank">revenue surged 31% year-over-year to 6.65 billion Yen</a> in Q1 2024.</p>



<p>Despite this impressive performance, freee&rsquo;s stock is still down nearly 78% from its all-time high. A weakening Japanese Yen has been a headwind for the company. However, I think the worst may be over for the stock. As global interest rates stabilize and the Yen potentially recovers, investor sentiment toward Japanese equities could improve.</p>



<p>Japan is finally ending its negative interest rate policy, and I expect the macroeconomic environment to become more favorable for growth stocks like freee.</p>



<p><em>On the date of publication, Omor Ibne Ehsan did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a></em>.</p>



<p><em>On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.</em></p>
<div><p>Omor Ibne Ehsan is a writer at InvestorPlace. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks. You can follow him on <a href="https://www.linkedin.com/in/omor-ibne-ehsan-56068022b/">LinkedIn</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/07/7-growth-stocks-that-could-5x-in-5-years/">7 Growth Stocks That Could 5X in 5 Years</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Freee

News

Latest news for Freee (OTC:FREKF) Stock